Hospital News and Research

RSS

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

Synthetic sutures appear to cause less pain than natural "catgut" sutures in women who receive stitches after a vaginal birth, according to a new review of studies.

16 Jun 2010

University of Montreal scientists discover free radical mechanism to viral invasion

Canadian researchers have discovered a new way the body combats respiratory viral infections. In the prestigious journal PLoS Pathogens, scientists from the University of Montreal and the University of Montreal Hospital Research Center explain how the NOX2 molecule, an enzyme that generates a burst of highly reactive oxygen derivatives (or free radicals), activates defense genes and molecules when viruses invade lung cells.

16 Jun 2010

Study examines survival rates of CF patients with MRSA

A team of researchers led by Elliott Dasenbrook, MD, MHS, Assistant Professor of Medicine and Pediatrics at Case Western Reserve University School of Medicine and Associate Director of the Adult Cystic Fibrosis Program at University Hospitals Case Medical Center's Rainbow Babies & Children's Hospital today published the findings from a major study about cystic fibrosis survival rates in the June 16 issue of JAMA.

16 Jun 2010

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Acclaimed virologist Robert Webster, Ph.D., of St. Jude Children's Research Hospital, presented the 2010 Leeuwenhoek prize lecture today, a prestigious recognition awarded by the Royal Society in London.

16 Jun 2010

Apollo Health Street announces second agreement with MCHS

Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, announced today a second agreement with Mississippi County Hospital System which comprises two hospitals - SMC Regional Medical Center in Osceola, AR and Great River Medical Center in Blytheville, AR.

16 Jun 2010

BIOTRONIK announces 10th anniversary of world's first wireless, mobile patient monitoring technology

BIOTRONIK SE & Co KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, today announced the tenth anniversary of BIOTRONIK Home Monitoring®—the world's first wireless, mobile patient monitoring technology—to be celebrated during Cardiostim in Nice, France.

16 Jun 2010

Study validates Grm1 protein as target for melanoma treatment

Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology further validate the team's clinical and pre-clinical findings that blocking the signaling normally activated by a receptor called Grm1 results in decreased cell growth and decreased migration of melanoma cells, confirming that Grm1 is a potential target for the treatment of melanoma.

16 Jun 2010

New data from Phase 2a trial support further development of BMS-945429/ALD518 monoclonal antibody for RA

Bristol-Myers Squibb Company and Alder Biopharmaceuticals today announced that new data from a dose-ranging Phase 2a trial support further development of BMS-945429/ALD518, an investigational monoclonal antibody directed against interleukin-6 (IL-6), as a potential treatment for rheumatoid arthritis (RA). The Phase 2a data will be presented in a scientific session on June 18, 2010, at the Annual Congress of the European League against Rheumatism (EULAR).

16 Jun 2010

New data shows Ohio children with special health care needs have inadequate insurance coverage

A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.

16 Jun 2010

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

16 Jun 2010

European Commission grants Orphan Medicinal Product Designation for QPI-1002

Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that the European Commission has granted Orphan Medicinal Product Designation for QPI-1002 (also referred to as "I5NP") for the prophylaxis of delayed graft function in kidney transplant patients.

16 Jun 2010

UT Southwestern head and neck cancer surgeons perform area's first transoral robotic surgery

Head and neck cancer surgeons at UT Southwestern Medical Center performed the area's first transoral robotic surgery (TORS), a recently approved minimally invasive no-scar procedure to remove tumors in the throat.

16 Jun 2010

Vitamin D may help reduce incidence, severity of viral respiratory tract infections: Study

Vitamin D may help reduce the incidence and severity of viral respiratory tract infections including influenza, according to a new study conducted by investigators at Greenwich Hospital and Yale University School of Medicine.

16 Jun 2010

New cancer research centre launched in Edinburgh

Edinburgh today (Wednesday) becomes the next link in a unique chain of Cancer Research UK Centres that are being launched across the UK.

16 Jun 2010

New combination appears to be effective against cancer stem cells in pancreatic cancer

The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, (Managing Director: Professor Dr. Markus W. B-chler) in cooperation with the German Cancer Research Center, tested the new substance in mice and pancreatic cancer cells.

16 Jun 2010

UOHI tests Canada's first in-hospital program to screen and treat patients for diabetes

The University of Ottawa Heart Institute is testing Canada's first in-hospital program to screen and treat patients for diabetes, a growing epidemic in much of the Western world. The program is expected to lead to new ways to identify and cope with one of the most important risk factors for heart disease, particularly in women.

16 Jun 2010

Elite medical schools rate poorly on social mission

A new study ranking the social mission of medical schools puts historically black colleges on top and some Northeast private schools at the bottom.

16 Jun 2010

UIC receives $3M grant to evaluate comprehensive process for responding to patient harm events

The University of Illinois at Chicago's Institute for Patient Safety Excellence has received a $3 million grant to evaluate its comprehensive process for responding to patient harm events at nine other Chicago area hospitals.

16 Jun 2010

“Devastating” evidence against Dr. Jayant Patel

Dr. Jayant Patel, 60, is pleading not guilty to the manslaughter of Mervyn Morris, Gerry Kemps and James Phillips and grievous bodily harm to Ian Vowles during his time as director of surgery at the Bundaberg Base Hospital between 2003 and 2005. In new developments the Brisbane Supreme Court heard many medical specialists give evidence against Patel’s decision to operate on Mr. Phillips in May 2003 who later died.

15 Jun 2010

CLC bio headed molecular diagnostics project receives $2M grant

CLC bio, Ion Torrent, and Aarhus University Hospital - Departments of Molecular Medicine and Clinical Genetics, have received a 2 million USD grant from the Danish National Advanced Technology Foundation.

15 Jun 2010

Hospital News and Research

Synthetic sutures less painful than natural "catgut" sutures after vaginal birth

University of Montreal scientists discover free radical mechanism to viral invasion

Study examines survival rates of CF patients with MRSA

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Apollo Health Street announces second agreement with MCHS

BIOTRONIK announces 10th anniversary of world's first wireless, mobile patient monitoring technology

Study validates Grm1 protein as target for melanoma treatment

New data from Phase 2a trial support further development of BMS-945429/ALD518 monoclonal antibody for RA

New data shows Ohio children with special health care needs have inadequate insurance coverage

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

European Commission grants Orphan Medicinal Product Designation for QPI-1002

UT Southwestern head and neck cancer surgeons perform area's first transoral robotic surgery

Vitamin D may help reduce incidence, severity of viral respiratory tract infections: Study

New cancer research centre launched in Edinburgh

New combination appears to be effective against cancer stem cells in pancreatic cancer

UOHI tests Canada's first in-hospital program to screen and treat patients for diabetes

Elite medical schools rate poorly on social mission

UIC receives $3M grant to evaluate comprehensive process for responding to patient harm events

“Devastating” evidence against Dr. Jayant Patel

CLC bio headed molecular diagnostics project receives $2M grant

Pioneering Live Cell Imaging - Yokogawa's Impact and Innovations

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Latest News